Choksi Laborator

{
  "main_header": {
    "sid": 525405,
    "name": "Choksi Laborator",
    "stock_name": "Choksi Laborator",
    "full_name": "Choksi Laboratories Ltd",
    "name_url": "stocks-analysis/choksi-laborator",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "127.80",
    "chg": 5.8,
    "chgp": "4.75%",
    "dir": 1,
    "prev_price": "122.00",
    "mcapval": "89.02 Cr",
    "mcap": "Micro Cap",
    "scripcode": 526546,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE493D01013",
    "curr_date": "Jun 04, 10:08 AM",
    "curr_time": "10:12 AM",
    "last_traded_at": "Jun 04, 10:08 AM IST",
    "bse_nse_vol": "10 ",
    "exc_status": "Active",
    "traded_date": "Jun 04, 2026",
    "traded_date_str": "2026 06 04",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/choksi-laborator-525405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-4033324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ChoksiLaborator_mojoScore_4033324.png",
        "date": "2026-06-03 10:11:38",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Are Choksi Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-choksi-laboratories-ltd-latest-results-good-or-bad-4014833",
        "imagepath": "",
        "date": "2026-05-26 19:23:06",
        "description": "Choksi Laboratories Ltd's latest financial results for Q4 FY26 reflect a notable rebound in profitability, with net profit reported at ₹1.03 crores, marking a significant sequential increase from ₹0.31 crores in the previous quarter. This improvement is attributed to a robust revenue growth of 12.46% year-on-year, reaching net sales of ₹12.82 crores, which is the highest quarterly revenue in the company's recent history. The operating margin also showed positive movement, expanding to 28.39% from 24.49% in Q3 FY26.\n\nHowever, while the quarterly performance indicates a recovery, the annual perspective reveals persistent challenges. The year-on-year net profit growth of 11.96% is modest compared to the previous year's growth rate of 35.29%, suggesting that the company is struggling to convert revenue growth into substantial profit expansion. Additionally, the return on equity (ROE) remains low at 6.50%, indic..."
      },
      {
        "title": "Choksi Laboratories Q4 FY26: Strong Profit Rebound Masks Underlying Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/choksi-laboratories-q4-fy26-strong-profit-rebound-masks-underlying-concerns-4013712",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_quaterlyResult_4013712.png",
        "date": "2026-05-26 09:50:07",
        "description": "Choksi Laboratories Ltd., a contract testing and analytical services provider, reported a sharp recovery in quarterly profit for Q4 FY26, with net profit surging to ₹1.03 crores—a dramatic 232.26% increase quarter-on-quarter and 11.96% year-on-year. However, beneath this headline improvement lies a concerning narrative of operational challenges, elevated debt levels, and weak returns on capital that continue to constrain the micro-cap company's investment appeal. Trading at ₹140.00 with a market capitalisation of ₹98.00 crores, the stock has gained 29.21% over the past year but remains 40.85% below its 52-week high of ₹236.70."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvements-despite-flat-financials-4002206",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_mojoScore_4002206.png",
        "date": "2026-05-21 08:03:47",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 May 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain subdued. The stock’s recent price surge of 12.42% and improved technical signals contrast with flat quarterly financials and weak long-term fundamentals, presenting a complex picture for investors."
      },
      {
        "title": "When is the next results date for Choksi Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-choksi-laboratories-ltd-3999631",
        "imagepath": "",
        "date": "2026-05-19 23:17:08",
        "description": "Choksi Laboratories Ltd is scheduled to declare its results on 25 May 2026...."
      },
      {
        "title": "Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-downgraded-to-strong-sell-amid-technical-and-fundamental-weakness-3998070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_mojoScore_3998070.png",
        "date": "2026-05-19 08:05:13",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 18 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and concerns over valuation and long-term fundamentals, signalling caution for investors amid a challenging market environment."
      },
      {
        "title": "Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-upgraded-to-sell-on-technical-improvement-despite-flat-financials-3986589",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_mojoScore_3986589.png",
        "date": "2026-05-12 08:06:54",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 11 May 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors."
      },
      {
        "title": "Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-downgraded-to-strong-sell-amid-weak-fundamentals-and-bearish-technicals-3974900",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ChoksiLaborator_mojoScore_3974900.png",
        "date": "2026-05-05 08:05:34",
        "description": "Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 4 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weak fundamental metrics, signalling heightened risks for investors amid challenging market conditions."
      },
      {
        "title": "Choksi Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/choksi-laboratories-ltd-is-rated-sell-3963000",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ChoksiLaborator_mojoScore_3963000.png",
        "date": "2026-04-26 10:10:34",
        "description": "Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 301,
    "sid": "525405",
    "stock_news_url": "https://www.marketsmojo.com/news/choksi-laboratories-525405"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "26-May-2026",
      "details": "Submission of newspaper publication of financial result for the period ended 31.03.2026",
      "source": "BSE"
    },
    {
      "caption": "Result For The Quarter And Year Ended 31.03.2026",
      "datetime": "25-May-2026",
      "details": "Result as attached",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "25-May-2026",
      "details": "Submission of Annual Secretarial Compliance report under Regulation 24A issued by M/s Surabhi Agrawal & Associate for the year ended 31.03.2026",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Choksi Laboratories Ltd is Rated Sell

2026-06-03 10:11:38

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 20 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Are Choksi Laboratories Ltd latest results good or bad?

2026-05-26 19:23:06

Choksi Laboratories Ltd's latest financial results for Q4 FY26 reflect a notable rebound in profitability, with net profit reported at ₹1.03 crores, marking a significant sequential increase from ₹0.31 crores in the previous quarter. This improvement is attributed to a robust revenue growth of 12.46% year-on-year, reaching net sales of ₹12.82 crores, which is the highest quarterly revenue in the company's recent history. The operating margin also showed positive movement, expanding to 28.39% from 24.49% in Q3 FY26. However, while the quarterly performance indicates a recovery, the annual perspective reveals persistent challenges. The year-on-year net profit growth of 11.96% is modest compared to the previous year's growth rate of 35.29%, suggesting that the company is struggling to convert revenue growth into substantial profit expansion. Additionally, the return on equity (ROE) remains low at 6.50%, indic...

Read full news article

Choksi Laboratories Q4 FY26: Strong Profit Rebound Masks Underlying Concerns

2026-05-26 09:50:07

Choksi Laboratories Ltd., a contract testing and analytical services provider, reported a sharp recovery in quarterly profit for Q4 FY26, with net profit surging to ₹1.03 crores—a dramatic 232.26% increase quarter-on-quarter and 11.96% year-on-year. However, beneath this headline improvement lies a concerning narrative of operational challenges, elevated debt levels, and weak returns on capital that continue to constrain the micro-cap company's investment appeal. Trading at ₹140.00 with a market capitalisation of ₹98.00 crores, the stock has gained 29.21% over the past year but remains 40.85% below its 52-week high of ₹236.70.

Read full news article

Choksi Laboratories Ltd Upgraded to Sell on Technical Improvements Despite Flat Financials

2026-05-21 08:03:47

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 20 May 2026. This change reflects a nuanced shift primarily driven by technical indicators, even as the company’s fundamental and financial metrics remain subdued. The stock’s recent price surge of 12.42% and improved technical signals contrast with flat quarterly financials and weak long-term fundamentals, presenting a complex picture for investors.

Read full news article

When is the next results date for Choksi Laboratories Ltd?

2026-05-19 23:17:08

Choksi Laboratories Ltd is scheduled to declare its results on 25 May 2026....

Read full news article

Choksi Laboratories Ltd Downgraded to Strong Sell Amid Technical and Fundamental Weakness

2026-05-19 08:05:13

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 18 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and concerns over valuation and long-term fundamentals, signalling caution for investors amid a challenging market environment.

Read full news article

Choksi Laboratories Ltd Upgraded to Sell on Technical Improvement Despite Flat Financials

2026-05-12 08:06:54

Choksi Laboratories Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Strong Sell to Sell as of 11 May 2026. This change reflects a nuanced shift in the company’s technical outlook despite persistent fundamental challenges. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends present a mixed picture for investors.

Read full news article

Choksi Laboratories Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals

2026-05-05 08:05:34

Choksi Laboratories Ltd, a micro-cap player in the healthcare services sector, has been downgraded from a Sell to a Strong Sell rating by MarketsMOJO as of 4 May 2026. This revision reflects deteriorating technical indicators, stagnant financial performance, and weak fundamental metrics, signalling heightened risks for investors amid challenging market conditions.

Read full news article

Choksi Laboratories Ltd is Rated Sell

2026-04-26 10:10:34

Choksi Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News